Treatment strategies to combat cardiogenic shock (CS) have remained stagnant over the
past decade. Mortality rates among patients who suffer CS after acute myocardial infarction …

Purpose Cardiogenic shock is associated with high mortality. In refractory shock, it is unclear
if mechanical circulatory support (MCS) devices improve survival. We conducted a network …

Aims This study aimed to give contemporary insight into the use of Impella and venoarterial
extracorporeal membrane oxygenation (VA‐ECMO) in acute myocardial infarction‐related …

The management of cardiogenic shock is an ongoing challenge. Despite all efforts and
tremendous use of resources, mortality remains high. Whilst reversing the underlying cause …

Objective Studies on extracorporeal membrane oxygenation (ECMO) with and without an
intra-aortic balloon pump (IABP) for cardiogenic shock (CS) have been published, but there …

Aims Cardiogenic shock (CS) is a state of low cardiac output resulting in end-organ
hypoperfusion. Despite high in-hospital mortality rates, little evidence exists regarding the …

Background Myocarditis in context of a SARS-CoV-2 infection is vividly discussed in the
literature. Real-world data however are sparse, and relevance of the myocarditis diagnosis …

Background Temporary mechanical circulatory support (MCS) is often used in patients with
cardiogenic shock (CS), and the type of MCS may vary by cause of CS. Objectives This …

Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) is associated with
high morbidity and mortality. Our study aimed to gain insights into patient characteristics …

BACKGROUND: Percutaneous microaxial ventricular assist devices (pVADs) have the
potential to reduce mortality of patients with cardiogenic shock (CS). However, the …